SCHEMBL8686347

SCHEMBL8686347

CC(=O)CCCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O

nearest known ligand 0.97

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 6/20 0.97
TNF P01375 4/20 0.97
LMNA P02545 2/20 0.97
CYP1A2 P05177 2/20 0.97
NFKB1 P19838 2/20 0.97
ACHE P22303 2/20 0.97
PDE4A P27815 2/20 0.97
PMP22 Q01453 2/20 0.97
RXFP1 Q9HBX9 2/20 0.97
USP2 O75604 1/20 0.97
TSHR P16473 1/20 0.97
PDE4B Q07343 1/20 0.97
PDE4C Q08493 1/20 0.97
PDE4D Q08499 1/20 0.97
SMN1; SMN2 Q16637 1/20 0.97
BLM P54132 2/20 0.72
ESR1 P03372 1/20 0.72
MAPT P10636 1/20 0.72
MAPK1 P28482 1/20 0.62
AKR1B1 P15121 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8687521 1.00 ADORA2B (0.97) ADORA2BTNFLMNACYP1A2NFKB1
SCHEMBL9123561 1.00 ADORA2B (0.97) ADORA2BTNFLMNACYP1A2NFKB1
SCHEMBL8686071 1.00 ADORA2B (0.97) ADORA2BTNFLMNACYP1A2NFKB1
SCHEMBL8696287 1.00 ADORA2B (0.97) ADORA2BTNFLMNACYP1A2NFKB1
SCHEMBL9123538 1.00 ADORA2B (0.97) ADORA2BTNFLMNACYP1A2NFKB1
SCHEMBL8150960 1.00 ADORA2B (0.97) ADORA2BTNFLMNACYP1A2NFKB1
SCHEMBL8687852 1.00 ADORA2B (0.97) ADORA2BTNFLMNACYP1A2NFKB1
Pentoxifylline SCHEMBL34039 0.99 ADORA2B (1.00) ADORA2BTNFLMNACYP1A2NFKB1
Pentoxifylline SCHEMBL3986204 0.99 ADORA2B (1.00) ADORA2BTNFLMNACYP1A2NFKB1
Pentoxifylline SCHEMBL8140331 0.97 ADORA2B (0.97) ADORA2BTNFLMNACYP1A2NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5770595-A Oxime substituted therapeutic compounds CELL THERAPEUTICS, INC. (US) 1998-06-23 US disclosed
WO-1995020589-A1 CELL SIGNALING INHIBITORS CELL THERAPEUTICS, INC. (US) 1995-08-03 WO disclosed
WO-1994016704-A1 OXIME-SUBSTITUTED THERAPEUTIC COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-08-04 WO disclosed